Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
International orders may take longer, depending on customs and local postal services
Funding The authors gratefully acknowledge the financial support from the Indian Institute of Technology Indore for the provision of conducting research and DST, Govt
While tirzepatide (Zepbound and Mounjaro) currently leads in terms of average weight loss in approved medications, CagriSema could become a strong competitor once Phase 3 results are released
Learn more Zepbound is a prescription medicine
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
PMC 7386876
US$ 24.11
US$ 20.23
US$ 24.24
US$ 27.37
US$ 21.44
